ClinicalTrials.Veeva

Menu

Efficacy and Safety of Flexible Ureteroscopy Versus Percutaneous Nephrolithotomy in Management of Staghorn Stones

M

Menoufia University

Status

Not yet enrolling

Conditions

Renal Stones

Treatments

Procedure: Percutaneous nephrolithotomy
Procedure: Flexible ureteroscopy

Study type

Interventional

Funder types

Other

Identifiers

NCT07322471
PCNL vs FURS in staghorn stone

Details and patient eligibility

About

Percutaneous nephrolithotomy (PCNL) is considered the treatment of choice for management of large renal calculi larger than 2 cm based on the yearly updated European Association of Urology (EAU) guidelines. However, PCNL is a challenging procedure which may be associated with several complications ranging from mild complications, such as urinary extravasation, leakage, infection and bleeding requiring transfusion to sever complications, such as sepsis, injury to surrounding organs, persistent hematuria and renal function impairment. The overall complication rate varies based on patient factors and surgical expertise.

Not only serious complications that defer some endourologists from performing PCNL but also such procedure is contraindicated and avoided by surgeons in cases of retrorenal colon, morbidly obese patients, spinal abnormalities and bleeding diathesis. Therefore, retrograde intrarenal surgery (RIRS) or flexible ureteroscopy (FURS) is increasingly recognized as an effective alternative, particularly for patients seeking a minimally invasive approach with a lower risk of complications.

The best practice in dealing with renal stones using FURS can be achieved via preoperative stenting for 2-4 weeks, negative urine culture, ureteral access sheath (UAS) usage and optimizing laser settings. Compared to PCNL, FURS is a less challenging procedure with low learning curve, less invasive and less bleeding. However, the high cost, including laser usage cost, presenting costs and multisession costs, in addition to the high risk of postoperative infection are considered as major drawbacks of FURS.

RIRS is emerging as an effective, safe, minimally invasive alternative to PCNL. Yet, the success of RIRS in comparison to PCNL, especially in a single session, is still questionable and there is no consensus about it.

Enrollment

138 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adults aged ≥18 years.
  • Diagnosis of complete staghorn renal stones confirmed by non-contrast CT.
  • Negative urine culture.

Exclusion criteria

  • Congenital renal anomalies (e.g., horseshoe kidney, malrotation).
  • Coagulopathy or uncorrected bleeding disorder.
  • Pregnancy.
  • Previous ipsilateral renal surgery.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

138 participants in 2 patient groups

PCNL group
Active Comparator group
Description:
patients of this group will undergo percutanous nephrolithotomy
Treatment:
Procedure: Percutaneous nephrolithotomy
FURS group
Active Comparator group
Description:
Patients of this group will undergo flexible ureteroscopy
Treatment:
Procedure: Flexible ureteroscopy

Trial contacts and locations

1

Loading...

Central trial contact

Ammar Alorabi

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems